Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium

The midterm outcomes of AVNeo using autologous pericardium were satisfactory in 850 patients with various aortic valve diseases. However, further randomized, multicenter prospective studies are needed to confirm the results of the current study.